-Sulfonatocalix[4]arene Turns Peptide Aggregates into an Efficient Cell-penetrating Peptide

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2024 Oct 16

PMID 39411252

Authors

Mahsima Heydari

Najmeh Salehi

Reza Zadmard

Werner M Nau

Khosro Khajeh

Zahra Azizi

Amir Norouzy

Affiliations

Soon will be listed here.

Abstract

A novel cell-penetrating peptide (CPP) called -YR, with as a fluorescent probe, was developed. Initially, we aimed to use Y as a supramolecular host for water-insoluble drugs, with R driving the complex into cells. However, an unexpected hurdle was discovered; the peptide self-assembled into amorphous aggregates, rendering it ineffective for our intended purpose. Molecular dynamics simulations revealed that intermolecular cation-π interactions between arginine and tyrosine caused this aggregation. By decorating the R sidechains with -sulfonatocalix[4]arene (CX4), we successfully dissolved most of the aggregates, significantly improved the peptide's solubility and enhanced the cell uptake with MCF7 and A549 cells both direct penetration and endocytosis. The binding strength between CX4 and R, as well as the interaction between curcumin and tyrosines was quantified. Encouragingly, our results showed that -YR, with CX4, effectively delivered curcumin - as a model for poorly water-soluble drugs - into cells which exhibited potent anticancer activity. Using R/CX4 instead of the conventional R oligoarginine-based CPP simplifies peptide synthesis and offers higher yields. CX4 shows promise for addressing aggregation issues in other peptides that undergo a similar aggregation mechanism.

References

Huang C, Liu Y, Oh H, Guo D, Nau W, Hennig A . Cellular Uptake of Cell-Penetrating Peptides Activated by Amphiphilic p-Sulfonatocalix[4]arenes. Chemistry. 2024; 30(28):e202400174. DOI: 10.1002/chem.202400174. View

Zapadka K, Becher F, Gomes Dos Santos A, Jackson S . Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017; 7(6):20170030. PMC: 5665799. DOI: 10.1098/rsfs.2017.0030. View

Allolio C, Magarkar A, Jurkiewicz P, Baxova K, Javanainen M, Mason P . Arginine-rich cell-penetrating peptides induce membrane multilamellarity and subsequently enter via formation of a fusion pore. Proc Natl Acad Sci U S A. 2018; 115(47):11923-11928. PMC: 6255155. DOI: 10.1073/pnas.1811520115. View

Park J, Ryu J, Kim K, Lee H, Bahn J, Han K . Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. J Gen Virol. 2002; 83(Pt 5):1173-1181. DOI: 10.1099/0022-1317-83-5-1173. View

Queralt-Rosinach N, Mestres J . A canonical cation-π interaction stabilizes the agonist conformation of estrogen-like nuclear receptors. Eur Biophys J. 2010; 39(11):1471-5. DOI: 10.1007/s00249-010-0602-2. View

Choi S, Jeong W, Kang S, Lee M, Kim E, Ryu D . Differential self-assembly behaviors of cyclic and linear peptides. Biomacromolecules. 2012; 13(7):1991-5. DOI: 10.1021/bm3005947. View

Vives E, Brodin P, Lebleu B . A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997; 272(25):16010-7. DOI: 10.1074/jbc.272.25.16010. View

Guidotti G, Brambilla L, Rossi D . Cell-Penetrating Peptides: From Basic Research to Clinics. Trends Pharmacol Sci. 2017; 38(4):406-424. DOI: 10.1016/j.tips.2017.01.003. View

Komin A, Russell L, Hristova K, Searson P . Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges. Adv Drug Deliv Rev. 2016; 110-111:52-64. DOI: 10.1016/j.addr.2016.06.002. View

10.

Herce H, Garcia A, Cardoso M . Fundamental molecular mechanism for the cellular uptake of guanidinium-rich molecules. J Am Chem Soc. 2014; 136(50):17459-67. PMC: 4277769. DOI: 10.1021/ja507790z. View

11.

Islam M, Rauf A, Akash S, Trisha S, Nasim A, Akter M . Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives. Biomed Pharmacother. 2023; 170:116034. DOI: 10.1016/j.biopha.2023.116034. View

12.

Jain A, Sankararamakrishnan R . Dynamics of noncovalent interactions in all-α and all-β class proteins: implications for the stability of amyloid aggregates. J Chem Inf Model. 2011; 51(12):3208-16. DOI: 10.1021/ci200302q. View

13.

Vaezi Z, Bortolotti A, Luca V, Perilli G, Mangoni M, Khosravi-Far R . Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: The case of killerFLIP. Biochim Biophys Acta Biomembr. 2019; 1862(2):183107. DOI: 10.1016/j.bbamem.2019.183107. View

14.

Lazar A, Da Silva E, Navaza A, Barbey C, Coleman A . A new packing motif for para-sulfonatocalix[4]arene: the solid state structure of the para-sulfonatocalix[4]arene D-arginine complex. Chem Commun (Camb). 2004; (19):2162-3. DOI: 10.1039/b408863h. View

15.

Vasconcelos L, Lehto T, Madani F, Radoi V, Hallbrink M, Vukojevic V . Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy. Biochim Biophys Acta Biomembr. 2017; 1860(2):491-504. DOI: 10.1016/j.bbamem.2017.09.024. View

16.

Rothbard J, Kreider E, Vandeusen C, Wright L, Wylie B, Wender P . Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J Med Chem. 2002; 45(17):3612-8. DOI: 10.1021/jm0105676. View

17.

Fattahi P, Salehi N, Azizi Z, Mohammadi J, Norouzy A, Moazzeni S . Fluorescence labeling of anchor-modified Mart-1 peptide for increasing its affinity for HLA-A*0201: Hit two targets with one arrow. J Pept Sci. 2023; 29(9):e3480. DOI: 10.1002/psc.3480. View

18.

Gallivan J, Dougherty D . Cation-pi interactions in structural biology. Proc Natl Acad Sci U S A. 1999; 96(17):9459-64. PMC: 22230. DOI: 10.1073/pnas.96.17.9459. View

19.

Waters M . Aromatic interactions in peptides: impact on structure and function. Biopolymers. 2004; 76(5):435-45. DOI: 10.1002/bip.20144. View

20.

Sharifi S, Fathi N, Memar M, Hosseiniyan Khatibi S, Khalilov R, Negahdari R . Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives. Phytother Res. 2020; 34(8):1926-1946. DOI: 10.1002/ptr.6658. View